TrialThe Korean journal of internal medicine2019

Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.

Ho-Young Yhim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.